CVM Stock Analysis: Buy, Sell, or Hold?
CVM - Cel-Sci Corporation
$1.43
0.13 (10.00%)
▲
5d:
-15.88%
30d:
-69.18%
90d:
-70.82%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When CVM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called CVM this week
83% bullish • 1 bearish
83% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CVM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CVM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CVM is currently trading at $1.43, which is considered oversold relative to its 30-day fair value range of $1.79 to $4.25.
Technical Outlook: Technically, CVM is in a strong uptrend. Immediate support is located at $0.89, while resistance sits at $2.16. The stock is showing strong short-term momentum, up 10.0% recently.
Market Sentiment: CVM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.00 (+1648.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CVM is in a strong uptrend. Immediate support is located at $0.89, while resistance sits at $2.16. The stock is showing strong short-term momentum, up 10.0% recently.
Market Sentiment: CVM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.00 (+1648.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.79 -
$4.25
Company Quality Score
46/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Strong upward momentum (+10.0%)
- BULLISH: Trading 1648.3% below Wall St target ($25.00)
- CAUTION: 5-day price weakness (-15.9%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.79 -
$4.25
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.89
Resistance Level
$2.16
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.55
Wall Street Target
$25.00
(+1648.3%)
Revenue Growth (YoY)
-62.7%
Share & Embed Analysis
Last updated: May 18, 2026 9:47 AM ET
Data refreshes hourly during market hours. Next update: 10:47 AM
Data refreshes hourly during market hours. Next update: 10:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 61 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 58 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 57 HOLD |
